BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 355064)

  • 41. Therapeutic approaches for hepatobiliary disorders with ursodeoxycholic acid and bile-acid derivatives.
    Serfaty L; Poupon R
    Clin Res Hepatol Gastroenterol; 2012 Sep; 36 Suppl 1():S1. PubMed ID: 23141887
    [No Abstract]   [Full Text] [Related]  

  • 42. Bile acid concentrations in serum during infancy and childhood.
    Sandberg DH
    Pediatr Res; 1970 May; 4(3):262-7. PubMed ID: 5463656
    [No Abstract]   [Full Text] [Related]  

  • 43. Extrahepatic biliary atresia: diagnosis by serum bile acid patterns and response to cholestyramine.
    Morrissey KP; Javitt NB
    Surgery; 1973 Jul; 74(1):116-21. PubMed ID: 4715876
    [No Abstract]   [Full Text] [Related]  

  • 44. Serum bile acids (a new advance in the diagnosis of liver disease).
    Demers LM
    Ric Clin Lab; 1979; 9(1):1-4. PubMed ID: 493809
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serum conjugated bile acids in various liver diseases.
    Frosch B; Wagener H; Immich H
    Clin Chim Acta; 1968 Oct; 22(2):294-5. PubMed ID: 5687097
    [No Abstract]   [Full Text] [Related]  

  • 46. Serum bile acids in primary biliary cirrhosis.
    Bloomer JR; Allen RM; Klatskin G
    Arch Intern Med; 1976 Jan; 136(1):57-61. PubMed ID: 1247336
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bile acids in the diagnosis, pathology, and therapy of hepatobiliary diseases.
    Anwer MS; Meyer DJ
    Vet Clin North Am Small Anim Pract; 1995 Mar; 25(2):503-17. PubMed ID: 7785176
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Hepatobiliary diseases in the newborn and infants].
    Markoff NG
    Hippokrates; 1976 Aug; 47(3):211-25. PubMed ID: 783096
    [No Abstract]   [Full Text] [Related]  

  • 49. [The clinical significance of radioimmunologically determined serum bile acids as a new liver function test and the development of a new intravenous sulfolithoglycocholic acid (SLGC) stimulation test].
    Biffl H; Goebel R; Leb G
    Acta Med Austriaca; 1979; 6(4):113-20. PubMed ID: 552771
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of fasting serum bile acid concentration in patients with liver and gastrointestinal disorders.
    Samuelson K; Aly A; Johansson C; Norman A
    Scand J Gastroenterol; 1981; 16(2):225-34. PubMed ID: 7313533
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Discriminant function analysis applied to laboratory tests in patients with hepatobiliary disease.
    Ellis G; Goldberg DM
    Comput Biomed Res; 1979 Oct; 12(5):483-501. PubMed ID: 387334
    [No Abstract]   [Full Text] [Related]  

  • 52. [Clinical significance of serum bile acid radioimmunoassay in hepatobiliary diseases--with special reference to the CG/SLCG ratio (author's transl)].
    Oshiumi Y; Koga S; Kamoi I; Nishitani H; Ichiya Y; Ibayashi H; Matsuura K
    Radioisotopes; 1979 Oct; 28(10):630-5. PubMed ID: 531242
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interlaboratory agreement and handling variability for consistency of results in paired serum bile acid assays.
    Nanfelt M; Macphail C; Kennedy KC; Eickhoff J
    J Am Anim Hosp Assoc; 2012; 48(1):25-30. PubMed ID: 22186717
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The importance of the determination of primary bile acids in diseases of the digestive tract].
    Fucíková E; Kimlová I; Kuzela L; Vísek V
    Vnitr Lek; 1989 Sep; 35(9):885-9. PubMed ID: 2815604
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Comparison of the value of serum caffeine and bile acid concentrations as indicators of liver injury].
    Habior A; Ostrowski J; Trzeciak L; Wojciechowski K
    Pol Arch Med Wewn; 1990 Nov; 84(5):284-91. PubMed ID: 2075120
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Bile acids in chronic hepatopathies].
    Luciani A; Massari M; Montanari P; Nora A; Zandomeneghi R
    Minerva Med; 1986 Dec; 77(49-50):2287-92. PubMed ID: 3808385
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A Laboratory Diagnostic Approach to Hepatobiliary Disease in Small Animals.
    Chapman SE; Hostutler RA
    Clin Lab Med; 2015 Sep; 35(3):503-19. PubMed ID: 26297400
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Determination of serum bile acids in hepatobiliary diseases. Clinical applicability].
    Pagani A; Pranzo A; Galante T
    Minerva Med; 1984 Jan; 75(3-4):99-107. PubMed ID: 6700830
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serum bile acids in primary biliary cirrhosis.
    Murphy GM; Ross A; Billing BH
    Gut; 1972 Mar; 13(3):201-6. PubMed ID: 5024725
    [TBL] [Abstract][Full Text] [Related]  

  • 60. HPLC assay of conjugated bile acids in human fluids using on-line sample pretreatment on a standard isocratic chromatograph.
    Scalia S; Pazzi P
    Clin Chim Acta; 1994 Jan; 224(2):181-90. PubMed ID: 8004788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.